BAL PHARMA
Back to All Ratios
|
BAL PHARMA Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 1.30 | 1.17 | 0.99 | 0.77 | 0.68 |
What is the latest EV/CE ratio of BAL PHARMA ?
Year | EV/CE |
---|---|
Mar2024 | 1.30 |
Mar2023 | 1.17 |
Mar2022 | 0.99 |
Mar2021 | 0.77 |
Mar2020 | 0.68 |
How is EV/CE of BAL PHARMA Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 1.3 | 11.11 | |
Mar2023 | 1.17 | 18.18 | |
Mar2022 | 0.99 | 28.57 | |
Mar2021 | 0.77 | 13.24 | |
Mar2020 | 0.68 | - |
Other Financial Ratios of BAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹153.9 Cr | -0.2% | -6.1% | -18.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -6% | -7.3% | -12% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -0.2% |
-6.1% |
-18.4% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses